Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.47 USD | +0.85% | +1.28% | +100.21% |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Drug Retailers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+100.21% | 678M | - | ||
+16.81% | 3.01B | D+ | ||
+17.18% | 1.73B | - | ||
+5.00% | 492M | - | ||
+50.70% | 186M | - | ||
+0.11% | 104M | - | ||
+1.67% | 98.08M | - | - | |
+42.70% | 53.21M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- GLASF Stock
- Ratings Glass House Brands Inc.